Ipsen to acquire Kartos Therapeutics for up to $1.75 billion
Ipsen to acquire Kartos Therapeutics for up to $1.75 billion
Ipsen to acquire Kartos Therapeutics for up to $1.75 billion
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.